Safety and efficacy of 333369 [carisbamate] in the treatment of partial epilepsy
Phase of Trial: Phase II
Latest Information Update: 02 Nov 2018
At a glance
- Drugs Carisbamate (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors SK Life Science
- 01 Aug 2012 Actual initiation date (Feb 2005) added as reported by ClinicalTrials.gov.
- 30 Nov 2007 Results have been reported at AES 2007 (1088724)
- 09 Aug 2007 Status changed from in progress to completed.